Literature DB >> 27744763

A review of trazodone use in psychiatric and medical conditions.

Hani Raoul Khouzam1,2.   

Abstract

Trazodone is an antidepressant that is FDA-approved for the treatment of depression. It has been used by mental health and primary care providers for the treatment of multiple psychiatric and medical conditions .This review describes trazodone mechanism of action, formulation, dosage and adverse effects and then summarizes the beneficial effects of trazodone in the treatment of various psychiatric and medical conditions such as major depression, as well non-approved FDA indications such as insomnia,anxiety disorders, posttraumatic stress disorder, obsessive compulsive disorder, feeding and eating disorders, substance use disorders, behavioral disturbances associated with cognitive dysfunction, sexual dysfunction, certain pain conditions, and rehabilitation after acute ischemic stroke. Despite trazodone's favorable effects in the treatment of FDA-unapproved psychiatric and medical conditions, large, randomized controlled clinical trials are still needed to confirm its efficacy in the treatment of the multiple conditions for which it is often used in clinical practice.

Entities:  

Keywords:  Trazodone; major depressive disorder; medical conditions; pharmacology; psychiatric disorders; serotonin receptor antagonists and reuptake inhibitors

Mesh:

Substances:

Year:  2016        PMID: 27744763     DOI: 10.1080/00325481.2017.1249265

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  9 in total

1.  Trazodone Prescribing for Children With Attention Deficit Hyperactivity Disorder on Medicaid in Oregon.

Authors:  Tracy A Klein; Janessa M Graves; Shannon Panther
Journal:  J Pediatr Pharmacol Ther       Date:  2022-02-09

Review 2.  Effects of Melatonin on Liver Injuries and Diseases.

Authors:  Jiao-Jiao Zhang; Xiao Meng; Ya Li; Yue Zhou; Dong-Ping Xu; Sha Li; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2017-03-23       Impact factor: 5.923

3.  Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.

Authors:  Anna Welz; Marcin Koba; Piotr Kośliński; Joanna Siódmiak
Journal:  J Clin Med       Date:  2022-03-22       Impact factor: 4.241

4.  Forensic Aspects of a Fatal Intoxication Involving Acetaminophen, Citalopram and Trazodone: A Case Report.

Authors:  Giulio Mannocchi; Roberta Tittarelli; Flaminia Pantano; Francesca Vernich; Margherita Pallocci; Pierluigi Passalacqua; Michele Treglia; Luigi Tonino Marsella
Journal:  Toxics       Date:  2022-08-22

5.  Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.

Authors:  Martin Schulze Westhoff; Adrian Groh; Sebastian Schröder; Phileas Johannes Proskynitopoulos; Kirsten Jahn; Martin Klietz; Benjamin Krichevsky; Dirk O Stichtenoth; Felix Wedegärtner; Stefan Bleich; Helge Frieling; Johannes Heck
Journal:  J Neural Transm (Vienna)       Date:  2022-09-02       Impact factor: 3.850

6.  Fan the flame: trazodone-induced mania in a unipolar depressed patient with stable sertraline treatment.

Authors:  Jianbo Hu; Jianbo Lai; Hanzhi Zheng; Shaohua Hu; Yi Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-24       Impact factor: 2.570

7.  Structural determinants influencing halogen bonding: a case study on azinesulfonamide analogs of aripiprazole as 5-HT1A, 5-HT7, and D2 receptor ligands.

Authors:  Krzysztof Marciniec; Rafał Kurczab; Maria Książek; Ewa Bębenek; Elwira Chrobak; Grzegorz Satała; Andrzej J Bojarski; Joachim Kusz; Paweł Zajdel
Journal:  Chem Cent J       Date:  2018-05-11       Impact factor: 4.215

Review 8.  The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases.

Authors:  Wioletta Rozpędek-Kamińska; Natalia Siwecka; Adam Wawrzynkiewicz; Radosław Wojtczak; Dariusz Pytel; J Alan Diehl; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 5.923

9.  A Case of Trazodone Overdose Successfully Rescued With Lipid Emulsion Therapy.

Authors:  Roger Taylor; Joshua Burg; Jeff Mullen
Journal:  Cureus       Date:  2020-10-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.